Urbanization and geographic expansion of zoonotic arboviral diseases: Mechanisms and potential strategies for prevention

Trends in Microbiology

Volumn 21, Issue 8, 2013, Pages 360-363

  Weaver, Scott C ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

Arbovirus; Mosquito; Prevention of transmission; Urban

Indexed keywords

DENGUE VACCINE; INSECTICIDE; YELLOW FEVER VACCINE;

ARBOVIRUS; CHIKUNGUNYA; CHIKUNGUNYA ALPHAVIRUS; DENGUE; DENGUE VIRUS; DISEASE CARRIER; ENVIRONMENTAL SANITATION; EPIDEMIC; GEOGRAPHIC DISTRIBUTION; HUMAN; INFECTION PREVENTION; MOSQUITO; NOTE; PATHOGENESIS; PRIORITY JOURNAL; URBANIZATION; VECTOR CONTROL; VIRUS TRANSMISSION; YELLOW FEVER; YELLOW FEVER FLAVIVIRUS; ZOONOSIS;

ARBOVIRUS; MOSQUITO; PREVENTION OF TRANSMISSION; URBAN;

ANIMALS; ARBOVIRUS INFECTIONS; HUMANS; TOPOGRAPHY, MEDICAL; URBANIZATION; ZOONOSES;

EID: 84881002390     PISSN: 0966842X     EISSN: 18784380     Source Type: Journal    
DOI: 10.1016/j.tim.2013.03.003     Document Type: Note

References (15)

1. Arnold C. West Nile virus bites back. Lancet Neurol. 2012, 11:1023-1024.
2. Coffey L.L., et al. Factors shaping the adaptive landscape for arboviruses: implications for the emergence of disease. Future Microbiol. 2013, 8:155-176.
3. Weaver S.C., Reisen W.K. Present and future arboviral threats. Antiviral Res. 2009, 85:328-345.
4. Simmons C.P., et al. Dengue. N. Engl. J. Med. 2012, 366:1423-1432.
5. Vasilakis N., et al. Fever from the forest: prospects for the continued emergence of sylvatic dengue virus and its impact on public health. Nat. Rev. Microbiol. 2011, 9:532-541.
6. Gubler D.J. Dengue, urbanization and globalization: the unholy trinity of the 21st century. Trop. Med. Health 2011, 39:3-11.
7. Jentes E.S., et al. The revised global yellow fever risk map and recommendations for vaccination, 2010: consensus of the Informal WHO Working Group on Geographic Risk for Yellow Fever. Lancet Infect. Dis. 2011, 11:622-632.
8. Bryant J.E., et al. Out of Africa: a molecular perspective on the introduction of yellow fever virus into the Americas. PLoS Pathog. 2007, 3:e75.
9. Duffy M.R., et al. Zika virus outbreak on Yap Island, Federated States of Micronesia. N. Engl. J. Med. 2009, 360:2536-2543.
10. Tesh R.B. The emerging epidemiology of Venezuelan hemorrhagic fever and Oropouche fever in tropical South America. Ann. N. Y. Acad. Sci. 1994, 740:129-137.
11. Maciel-de-Freitas R., et al. Why do we need alternative tools to control mosquito-borne diseases in Latin America?. Mem. Inst. Oswaldo Cruz 2012, 107:828-829.
12. Sabchareon A., et al. Protective efficacy of the recombinant, live-attenuated, CYD tetravalent dengue vaccine in Thai schoolchildren: a randomised, controlled Phase 2b trial. Lancet 2012, 380:1559-1567.
13. Weaver S.C., et al. Chikungunya virus and prospects for a vaccine. Expert Rev. Vaccines 2012, 11:1087-1101.
14. Honorio N.A., et al. Spatial evaluation and modeling of Dengue seroprevalence and vector density in Rio de Janeiro, Brazil. PLoS Negl. Trop. Dis. 2009, 3:e545.
15. Ramos M.M., et al. Epidemic dengue and dengue hemorrhagic fever at the Texas-Mexico border: results of a household-based seroepidemiologic survey, December 2005. Am. J. Trop. Med. Hyg. 2008, 78:364-369.